(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) announced the publication of clinical data from the open-label DAFFODIL study, which evaluated the long-term safety and efficacy of DAYBUE or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback